Novartis cancer chief to tackle TB
Alex Matter is to direct the Novartis Institute for Tropical
Diseases (NITD) in Singapore after his retirement as Novartis
oncology chief later ths month.
Central Europe a hotspot for drug trials
Leading CRO says it has seen a marked increase in the number of
trials it has been asked to work on in Central Europe, and believes
the trend is set to continue.
IBM unveils R&D productivity package
IBM has introduced its new InsightLink software, an application to
help pharma companies create searchable online databases that will
enable more sharing of research knowledge.
Edible vaccines closer to market
Transgenic plant technologies could lead to a revolution in vaccine
production and manufacture; should plant-based vaccines prove
effective in clinical trials, this will drive licensing activity
between key vaccine players and companies...
German health reforms drive out Pfizer, Merck
US pharmaceuticals major Pfizer is considering moving some of its
activities in Germany to the UK due to government health reforms;
meanwhile, Merck & Co has shelved plans to open a new R&D
facility in the country.
Long-term plasmid storage feasible
PlasmidFactory has published long-term stability data for its
plasmid DNA, raising the prospects for the technology as a new
source of APIs.
Molecular Probes acquisition
Invitrogen completes $325m purchase of Molecular Probes in a deal
which will take the latter's fluorescence labelling technologies
into new markets.
Merlin eyes Nordic region
UK-based life sciences venture firm Merlin Biosciences is expanding
its European practice into Finland by establishing an office in
FP6 information day for biopharmaceutical SMEs
The emerging biopharmaceutical enterprises (EBE) group will hold an
information day on priority one of the Sixth Framework Programme on
Why research? Just in-license
A new report suggests that pharmaceutical companies reap much
greater rewards from licensing in products than they do in
conducting their own in-house research.
Acumen Explorer price cut
TTP LabTech announced revamp of Explorer microplate range, as well
as price cuts, following its screening marriage with Acumen
Major MS component deal for Oxford Instruments
Oxford Instruments wins €3 million order for superconducting
magnets for use in Thermo Electron's Finnigan LTQ-FT mass
Astex in CYP450 alliance with Fujisawa
UK-based Astex Technology has revealed that it has signed a
structure-based drug discovery agreement with Japan's Fujisawa.
New clue to Alzheimer's pathology
Researchers have uncovered evidence that the first time that
neurotoxic peptide assemblies known as ADDLs are responsible for
Alzheimer's disease in humans.
Clariant beefs up clinical manufacturing support
Clariant has announced plans to establish a Technology Centre in
Germany that will support the pharmaceutical industry in the
commercialisation of new drugs.